212 related articles for article (PubMed ID: 23615182)
1. Association of chemokine gene variants with end stage renal disease in North Indian population.
Singh V; Jaiswal PK; Tiwari P; Kapoor R; Mittal RD
Transpl Immunol; 2013 Jun; 28(4):189-92. PubMed ID: 23615182
[TBL] [Abstract][Full Text] [Related]
2. Impact of chemokines CCR5∆32, CXCL12G801A, and CXCR2C1208T on bladder cancer susceptibility in north Indian population.
Singh V; Jaiswal PK; Kapoor R; Kapoor R; Mittal RD
Tumour Biol; 2014 May; 35(5):4765-72. PubMed ID: 24430363
[TBL] [Abstract][Full Text] [Related]
3. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
Manchanda PK; Kumar A; Kaul A; Mittal RD
Clin Chim Acta; 2006 Aug; 370(1-2):152-7. PubMed ID: 16545788
[TBL] [Abstract][Full Text] [Related]
4. Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population.
Singh V; Srivastava P; Srivastava N; Kapoor R; Mittal RD
Mol Biol Rep; 2012 Oct; 39(10):9827-34. PubMed ID: 22733495
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor gene polymorphisms in North Indian patients with end stage renal disease.
Prakash S; Prasad N; Sharma RK; Faridi RM; Agrawal S
Cytokine; 2012 May; 58(2):261-6. PubMed ID: 22370607
[TBL] [Abstract][Full Text] [Related]
6. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
7. Cytokine (IL-10 -1082 and -819) and chemokine receptor (CCR2 and CCR5) gene polymorphism in North Indian patients with end-stage renal disease.
Manchanda PK; Singh R; Mittal RD
DNA Cell Biol; 2009 Apr; 28(4):177-83. PubMed ID: 19196047
[TBL] [Abstract][Full Text] [Related]
8. Monocyte chemoattractant protein-1 (MCP-1) g.-2518A>G polymorphism and susceptibility to type 2 diabetes (T2D) and end stage renal disease (ESRD) in the North-West Indian population of Punjab.
Raina P; Matharoo K; Bhanwer AJ
Ann Hum Biol; 2015; 42(3):276-82. PubMed ID: 25154422
[TBL] [Abstract][Full Text] [Related]
9. Association of Transforming Growth Factor Beta-1 (TGF-β1) Genetic Variation with Type 2 Diabetes and End Stage Renal Disease in Two Large Population Samples from North India.
Raina P; Sikka R; Kaur R; Sokhi J; Matharoo K; Singh V; Bhanwer AJ
OMICS; 2015 May; 19(5):306-17. PubMed ID: 25871499
[TBL] [Abstract][Full Text] [Related]
10. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
Misra MK; Prakash S; Kapoor R; Pandey SK; Sharma RK; Agrawal S
Tissue Antigens; 2013 Nov; 82(5):317-26. PubMed ID: 24131018
[TBL] [Abstract][Full Text] [Related]
12. Association between vitamin D receptor gene polymorphisms and susceptibility to chronic kidney disease and periodontitis.
de Souza CM; Braosi AP; Luczyszyn SM; Avila AR; de Brito RB; Ignácio SA; Probst CM; Riella MC; Sotomaior VS; Mira MT; Pecoits-Filho R; Trevilatto PC
Blood Purif; 2007; 25(5-6):411-9. PubMed ID: 17914260
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
[TBL] [Abstract][Full Text] [Related]
14. Role of thrombotic risk factors in end-stage renal disease.
Tripathi G; Sankhwar SN; Sharma RK; Baburaj VP; Agrawal S
Clin Appl Thromb Hemost; 2010 Apr; 16(2):132-40. PubMed ID: 19520684
[TBL] [Abstract][Full Text] [Related]
15. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
16. Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease.
Mittal RD; Manchanda PK
Immunogenetics; 2007 Feb; 59(2):159-65. PubMed ID: 17203290
[TBL] [Abstract][Full Text] [Related]
17. Association of tumour necrosis factor-α polymorphism in patients with end stage renal disease.
Singh K; Prasad KN; Mishra P; Singh SK; Kharwar NK; Prasad N; Gupta A; Srivastava JK
Nephrology (Carlton); 2015 Jun; 20(6):387-91. PubMed ID: 25589331
[TBL] [Abstract][Full Text] [Related]
18. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
Ma RC; Tam CH; Wang Y; Luk AO; Hu C; Yang X; Lam V; Chan AW; Ho JS; Chow CC; Tong PC; Jia W; Ng MC; So WY; Chan JC
JAMA; 2010 Aug; 304(8):881-9. PubMed ID: 20736472
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease.
Duymaz-Tozkir J; Yilmaz V; Uyar FA; Hajeer AH; Saruhan-Direskeneli G; Gül A
J Rheumatol; 2005 Jan; 32(1):93-7. PubMed ID: 15630732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
